|
Orthologous residues
|
|
NR1I3 (human): T38‑p, NR1I3 (mouse): T48‑p, NR1I3 (rat): T48‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Disease tissue studied:
liver cancer
|
|
Relevant cell lines - cell types - tissues:
hepatocyte-liver, HepG2 (hepatic)
|
|
Cellular systems studied:
cell lines, primary cultured cells
|
|
Species studied:
human, mouse
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
inhibition, intracellular localization, molecular association, regulation, protein conformation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
DNA
|
|
Disrupts
|
|
|
in vitro
|
|
